Biotech, oil, bank shares boost TSE

Article Abstract:

The Toronto Stock Exchange ended up strong boosted by bids for biotechnical, oil and bank shares. The merger of BioChem Pharma Inc. and Shire Pharmaceuticals Group PLC drove up biotechnical stocks higher although Nortel Networks Corp., Ballard Power Systems Inc. and JDS Uniphase Corp. finished lower.

Canada, Securities & Commodities Exchanges, Securities and Commodity Exchanges, Security and commodity exchanges, Securities Exchanges, Market share, Biological Product (except Diagnostic) Manufacturing, Biological Products, Reports, Exchanges, Biological products industry, Securities industry, Nortel Networks Corp., NT, JDS Uniphase Corp. (San Jose, California), JDSU, Shire Pharmaceuticals Group PLC, Toronto Stock Exchange, Shire BioChem Inc., BCHE, Ballard Power Systems Inc., BLDPF

---

Few obstacles seen for Glaxo-SmithKline merger

Article Abstract:

The proposed $75.8 billion merger between Glaxo Wellcome PLC and SmithKline Beecham PLC will get careful review from regulatory bodies in the U.S. and Europe. Industry analysts said that the merger between the two United Kingdom drug makers is actually a takeover by Glaxo Wellcome.

United Kingdom, Acquisitions & mergers, Drugs & Pharmaceuticals, Pharmaceutical and Medicine Manufacturing, Pharmaceutical Preparation Manufacturing, Pharmaceutical preparations, Pharmaceutical industry, Mergers, acquisitions and divestments, Drugs, Glaxo Wellcome PLC, SmithKline Beecham PLC

---

Similar abstracts:

• Abstracts: Investors buy biotechs on news of merger. Ottawa approves biotech deal as probe launched. BioChem in blockbuster merger with Shire PLC
• Abstracts: U.S. chain set to fly in Canada. Winners seeks Dylex deal, sources say. Canadian Tire makes surprise Mark's Work Wearhouse bid

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.